The tumor grade and T, M, and N stages tended to be more posterior, which was also consistent with the results of ADAM12 in other tumors studied by other authors, indicating that ADAM12 can be a potential biomarker for ccRCC. The gene discussed is ADAM12; the disease is nonpapillary renal cell carcinoma.